DARE
Dare Bioscience Inc
NASDAQ · Pharmaceuticals
$1.69
+0.01 (+0.60%)
Open$1.73
Previous Close$1.68
Day High$1.75
Day Low$1.69
52W High$5.10
52W Low$2.18
Volume—
Avg Volume123.1K
Market Cap24.15M
P/E Ratio21.01
EPS$0.16
SectorPharmaceuticals
Analyst Ratings
Strong Buy
10 analysts
Price Target
+143.8% upside
Current
$1.69
$1.69
Target
$4.12
$4.12
$2.96
$4.12 avg
$5.49
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 6.97M | 6.37M | 6.18M |
| Net Income | 1.03M | 1.14M | 939.3K |
| Profit Margin | 14.8% | 17.9% | 15.2% |
| EBITDA | 1.81M | 1.58M | 1.73M |
| Free Cash Flow | 730.8K | 772.3K | 654.4K |
| Rev Growth | +17.6% | +7.5% | -4.9% |
| Debt/Equity | 0.70 | 0.72 | 0.69 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |